Standard initial therapy for patients without neurological involvement is 1000 mcg intramuscularly (i.m.) three times a week for 2 weeks
Researchers studying optimal treatment duration for GLP-1 therapies will find this particularly relevant
For instance, there was an initial decrease followed by a dramatic increase in beta-endorphin
Provides support for liver, brain, heart, lung, and eye health*
In contrast, adult immunization of this mouse strain, which is prone to develop diabetes, failed to protect, so timing was central to protection
Figure 4 Dihexa otoprotection is mediated by HGF/c-Met signaling We used the pharmacological inhibitor 6-AH to investigate if the observed protection conferred by Dihexa is actually mediated by HGF/c-Met signaling